CN111991535B - Traditional Chinese medicine extract with function of treating helicobacter pylori-associated gastritis and preparation method and application thereof - Google Patents
Traditional Chinese medicine extract with function of treating helicobacter pylori-associated gastritis and preparation method and application thereof Download PDFInfo
- Publication number
- CN111991535B CN111991535B CN202011040023.7A CN202011040023A CN111991535B CN 111991535 B CN111991535 B CN 111991535B CN 202011040023 A CN202011040023 A CN 202011040023A CN 111991535 B CN111991535 B CN 111991535B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- helicobacter pylori
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of traditional Chinese medicines, and particularly discloses a traditional Chinese medicine extract with a function of treating Hp-related gastritis, and a preparation method and application thereof. The traditional Chinese medicine extract is prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 5-14 parts of basil; 2-5 parts of fructus evodiae; 5-14 parts of zanthoxylum seeds; 5-14 parts of black nightshade; 8-16 parts of mock strawberry; 8-16 parts of agastache rugosus; 8-16 parts of eupatorium; 8-16 parts of fructus amomi; 15-25 parts of oriental wormwood; 8-16 parts of immature bitter orange; 8-16 parts of mangnolia officinalis and 2-12 parts of honey-fried licorice root. The traditional Chinese medicine extract with the function of treating the Hp-related gastritis provided by the invention has the advantages that the monarch, the minister, the assistant and the guide supplement each other, the whole formula has the effects of warming yang, eliminating turbidity and detoxifying, the traditional Chinese medicine extract is safe and reliable, has no toxic or side effect, can effectively improve the eradication rate of helicobacter pylori, can reduce the side effect of a bactericidal medicine, and promotes the repair of gastric mucosa, and has an obvious effect.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine extract with a function of treating Hp-related gastritis and a preparation method and application thereof.
Background
Helicobacter pylori (Hp) is a spiral gram-negative bacillus, a major causative agent of chronic gastritis, and has close relationship with the occurrence of peptic ulcer and gastric cancer.
At present, the prevalence rate of chronic gastritis based on endoscopic diagnosis in China is close to 90%, wherein the infection rate of Hp is about 52.2%. Hp infection can cause gastric mucosa inflammation change, Hp virulence factors cause abnormal regulation of signal pathways in gastric epithelial cells, gastric mucosa cells are further damaged, and long-term chronic inflammation can cause gastric mucosa ulcer and even malignant evolution of tumors. Thus, the world health organization classifies Hp as a class i carcinogen.
Modern medicine considers that after Hp infection, a radical treatment principle is a key step of treatment, and triple and quadruple bactericidal therapy is mostly adopted. However, with the increase of the Hp infection rate, the above treatment causes drug resistance of the organism, imbalance of intestinal flora, poor patient compliance and great side effects, so that a generally accepted treatment scheme does not exist at present. How to reduce the Hp infection rate and reduce the side effect of the medicine is still a problem which needs to be solved urgently in clinic.
Disclosure of Invention
Aiming at the technical problems of the existing Hp infection, the invention provides a traditional Chinese medicine extract with a function of treating Hp-related gastritis and a preparation method and application thereof.
In order to achieve the purpose of the invention, the embodiment of the invention adopts the following technical scheme:
the traditional Chinese medicine extract is prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 5-14 parts of basil; 2-5 parts of fructus evodiae; 5-14 parts of zanthoxylum seeds; 5-14 parts of black nightshade; 8-16 parts of mock strawberry; 8-16 parts of agastache rugosus; 8-16 parts of eupatorium; 8-16 parts of fructus amomi; 15-25 parts of oriental wormwood; 8-16 parts of immature bitter orange; 8-16 parts of mangnolia officinalis and 2-12 parts of honey-fried licorice root.
Further, the traditional Chinese medicine extract with the function of treating the Hp-related gastritis comprises the following components in parts by mass: 7-12 parts of basil; 2-4 parts of fructus evodiae; 7-12 parts of zanthoxylum seeds; 7-12 parts of black nightshade; 10-14 parts of mock strawberry; 10-14 parts of agastache rugosus; 10-14 parts of eupatorium; 10-14 parts of fructus amomi; 18-22 parts of oriental wormwood; 10-14 parts of immature bitter orange; 10-14 parts of mangnolia officinalis and 4-8 parts of honey-fried licorice root.
Further, the traditional Chinese medicine extract with the function of treating the Hp-related gastritis comprises the following components in parts by mass: 9 parts of basil; 3 parts of fructus evodiae; 9 parts of zanthoxylum seeds; 9 parts of black nightshade; 12 parts of Indian mockstrawberry herb; 12 parts of wrinkled gianthyssop herb; 12 parts of eupatorium; 12 parts of fructus amomi; 20 parts of oriental wormwood; 12 parts of immature bitter orange; 12 parts of magnolia officinalis and 6 parts of honey-fried licorice root.
In the present invention, basil: pungent and sweet in flavor and warm in nature; it enters lung, spleen, stomach and large intestine meridians; dispelling wind, relieving exterior syndrome, eliminating dampness, regulating the middle warmer, promoting qi and blood circulation, removing toxic substance, and relieving swelling; can be used for treating dyspepsia, anorexia, abdominal distention, pain, emesis, dysentery, and digestive tract ulcer.
Evodia fruit: pungent, bitter and hot in flavor; entering liver, spleen, stomach and kidney meridians; dispel cold and alleviate pain, check adverse rise of qi and arrest vomiting, strengthen yang and check diarrhea; can be used for treating gastralgia, vomiting and diarrhea due to cold of viscera, and syndrome of deficiency-cold of liver and stomach and adverse rising of yin-turbid.
Pepper seeds: bitter taste and cold nature; entering lung, kidney and bladder meridians; induce diuresis to alleviate edema, dispel phlegm and relieve asthma; can be used for anti-inflammatory and anti-tumor.
Black nightshade: bitter taste and cold nature; it enters kidney and spleen meridians. Clearing away heat and toxic materials, promoting blood circulation, and relieving swelling; it can be used for treating furuncle, carbuncle, swelling, and erysipelas.
The Indian strawberry: sweet, bitter and cold in nature; entering lung, liver and large intestine meridians; clearing away heat and toxic materials, removing blood stasis, relieving swelling, cooling blood, and stopping bleeding; the modern pharmacological research has the effects of resisting tumor and enhancing immunity.
Agastache rugosus: pungent taste and mild nature; spleen, stomach and lung meridians entered; fragrant, resolving dampness, regulating the middle warmer, relieving vomiting, relieving exterior syndrome and relieving summer-heat; is suitable for summer-heat and dampness stagnation, abdominal distention and fullness, and has spasmolytic, antiseptic, and antibacterial effects.
Herba Eupatorii: pungent taste and mild nature; spleen, stomach and lung meridians entered; fragrant, resolving dampness, activating spleen, stimulating appetite, relieving exterior syndrome and relieving summer-heat; can be used for treating damp retention in middle energizer, abdominal distention, vomiting, summer-heat dampness, and damp-warm disease.
Amomum fruit: pungent taste and warm nature; resolving dampness, promoting appetite, warming spleen and relieving diarrhea; can be used for treating abdominal distention, diarrhea, emesis, anorexia, and loose stool; and has the functions of strengthening stomach, helping digestion and eliminating flatulence symptoms.
Herba artemisiae scopariae: bitter, pungent and slightly cold in nature; spleen, stomach, liver and gallbladder meridians entered; clearing away damp-heat, promoting bile flow and eliminating jaundice; can be used for treating diseases such as summer-heat dampness, damp-warm disease, incoordination between liver and stomach, etc., and has antitumor, antipyretic, and hepatoprotective effects.
Immature bitter orange: bitter, pungent and sour in flavor, slightly cold in nature; spleen and stomach meridians entered; break qi, remove food retention, resolve phlegm and remove abdominal mass; has effects in treating gastrointestinal stagnation, damp-heat dysentery; regulating gastrointestinal motility, resisting ulcer, and inhibiting bacteria.
Magnolia officinalis: bitter and pungent taste, slightly warm in nature; the spleen, stomach, lung and large intestine meridians entered; eliminating dampness and phlegm, descending qi and eliminating fullness; for damp stagnation in the middle energizer, abdominal mass, vomiting and diarrhea, food stagnation, qi stagnation, abdominal distention, constipation, phlegm retention, asthma and cough; has antibacterial and gastric ulcer preventing effects.
Honey-fried licorice root: sweet in flavor, neutral in nature, entering stomach, heart, lung and spleen meridians; invigorating spleen and replenishing qi, eliminating phlegm and relieving cough, relieving spasm and pain, and harmonizing drug property; has the effects of treating weakness of the spleen and the stomach, harmonizing the effect of the medicines, resisting helicobacter pylori and resisting ulcer.
Compared with the prior art, the traditional Chinese medicine extract with the function of treating the Hp-related gastritis provided by the invention has the advantages that in 12 medicines, monarch, minister, assistant and guide supplement each other, wherein basil, evodia rutaecarpa and zanthoxylum seeds are pungent in flavor, warm in nature and can block, and cold dispelling and pain relieving are monarch; the black nightshade, the Indian mockstrawberry herb, the wrinkled giant hyssop herb and the fortune eupatorium herb are used as ministers with the functions of eliminating turbid pathogen with aromatics and clearing away heat and toxic materials; fructus Amomi, herba Artemisiae Scopariae, fructus Aurantii Immaturus, cortex Magnolia officinalis, and has effects in eliminating turbid pathogen with aromatics, activating spleen, and promoting qi circulation; the prepared licorice root, in combination with the other drugs, has the effects of warming yang, resolving turbidity and detoxifying. The invention aims to treat both principal and secondary aspects of disease, adopts the traditional Chinese medicine extract to be matched with the tetragenous bactericide, and regulates and controls the network through the inflammatory factors so as to achieve the aims of reducing the disease rate of Hp and reducing the side effect of the bactericide.
The invention also provides a preparation method of the traditional Chinese medicine extract for treating the Hp-related gastritis. The preparation method comprises the following steps: soaking herba Ocimi, fructus evodiae, semen Zanthoxyli, herba Solani Nigri, herba Duchesneae Indicae, herba Agastaches, herba Eupatorii, fructus Amomi, herba Artemisiae Scopariae, fructus Aurantii Immaturus, cortex Magnolia officinalis and radix Glycyrrhizae Preparata in water, heating, decocting, and filtering to obtain extractive solution.
The preparation method of the traditional Chinese medicine extract with the function of treating the Hp-related gastritis, which is provided by the invention, has the advantages of simple process, convenience in operation, safety and environmental friendliness, and can furthest retain active ingredients in the traditional Chinese medicine and ensure the efficacy of the medicine.
Furthermore, the soaking temperature is 15-25 ℃, the soaking time is 30-60 min, so that water is fully contacted with the traditional Chinese medicine, good soaking and permeating effects are achieved, the subsequent decoction and extraction are facilitated, and meanwhile, the decomposition of the effective components of the traditional Chinese medicine caused by long-time soaking is avoided.
Furthermore, the decoction temperature is 80-100 ℃, the time is 30-40 min, the active ingredients of the traditional Chinese medicine are not damaged, and the extraction rate is improved.
Furthermore, the water dosage is 6-8 times of the total mass of the traditional Chinese medicine, so that the leaching effect is ensured.
The invention also provides a traditional Chinese medicine preparation with the function of treating the Hp-related gastritis, which contains the traditional Chinese medicine extract with the function of treating the Hp-related gastritis.
The traditional Chinese medicine preparation with the function of treating Hp-related gastritis contains the traditional Chinese medicine extract, all medicines are combined, monarch, minister, assistant and guide supplement each other, the whole formula has the effects of warming yang, eliminating turbidity and detoxifying, and the four-combined bactericidal drug is matched, so that the traditional Chinese medicine preparation is safe and reliable, has no toxic or side effect, can effectively improve the eradication rate of helicobacter pylori, can reduce the side effect of the bactericidal drug, and promotes the repair of gastric mucosa.
Further, the traditional Chinese medicine preparation also comprises pharmaceutically acceptable auxiliary materials, wherein the auxiliary materials are selected from excipient, lubricant, disintegrant, filler and adhesive.
Furthermore, the dosage form of the traditional Chinese medicine preparation is oral liquid, capsules, tablets, granules or pills.
The invention also provides application of the traditional Chinese medicine extract with the function of treating the Hp-related gastritis in preparing a medicine with the function of treating the Hp-related gastritis.
The traditional Chinese medicine extract with the function of treating the Hp-related gastritis is prepared into different traditional Chinese medicine preparations by a conventional method.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
In order to better illustrate the traditional Chinese medicine extract for treating Hp-related gastritis provided by the embodiments of the present invention, the following examples further illustrate the extract.
Example 1
The traditional Chinese medicine extract is prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 5g of basil; 5g of fructus evodiae; 5g of zanthoxylum bungeanum maxim; 5g of black nightshade; 8g of mock strawberry; 8g of wrinkled gianthyssop herb; 8g of eupatorium fortunei; 8g of fructus amomi; 25g of oriental wormwood; 16g of immature bitter orange; 16g of magnolia officinalis and 2g of honey-fried licorice root.
The preparation method of the traditional Chinese medicine extract specifically comprises the following steps:
adding the basil, the evodia rutaecarpa, the pricklyash peel, the black nightshade, the Indian mockstrawberry herb, the wrinkled gianthyssop herb, the fortune eupatorium herb, the villous amomum fruit, the virgate wormwood herb, the immature bitter orange, the officinal magnolia bark and the honey-fried licorice root into water which is 6 times of the total mass of the traditional Chinese medicines, soaking for 40min at 25 ℃, heating to 100 ℃, decocting for 30min, and filtering to obtain leaching liquor so as to obtain the traditional Chinese medicine extract.
The traditional Chinese medicine extract with the function of treating the Hp-related gastritis is prepared into traditional Chinese medicine oral liquid by adopting a conventional method.
Example 2
The traditional Chinese medicine extract is prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 14g of basil; 2g of fructus evodiae; 14g of zanthoxylum bungeanum maxim; 14g of black nightshade; 16g of Indian mockstrawberry herb; 16g of wrinkled gianthyssop herb; 16g of eupatorium fortunei; 16g of fructus amomi; 15g of oriental wormwood; 8g of immature bitter orange; 8g of magnolia officinalis and 12g of honey-fried licorice root.
The preparation method of the traditional Chinese medicine extract specifically comprises the following steps:
adding the basil, the evodia rutaecarpa, the pricklyash peel, the black nightshade, the Indian mockstrawberry herb, the wrinkled gianthyssop herb, the fortune eupatorium herb, the villous amomum fruit, the virgate wormwood herb, the immature bitter orange, the officinal magnolia bark and the honey-fried licorice root into water which is 8 times of the total mass of the traditional Chinese medicines, soaking for 60min at 15 ℃, heating to 80 ℃, decocting for 40min, and filtering to obtain leaching liquor so as to obtain the traditional Chinese medicine extract.
The traditional Chinese medicine extract with the function of treating Hp-related gastritis is prepared into traditional Chinese medicine tablets by adopting a conventional method.
Example 3
The traditional Chinese medicine extract is prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 7g of basil; 2g of fructus evodiae; 7g of zanthoxylum bungeanum maxim; 7g of black nightshade; 10g of mock strawberry; 10g of wrinkled gianthyssop herb; 10g of eupatorium fortunei; 10g of fructus amomi; 18g of oriental wormwood; 10g of immature bitter orange; 10g of magnolia officinalis and 4g of honey-fried licorice root.
The preparation method of the traditional Chinese medicine extract specifically comprises the following steps:
adding the basil, the evodia rutaecarpa, the pricklyash peel, the black nightshade, the Indian mockstrawberry herb, the wrinkled gianthyssop herb, the fortune eupatorium herb, the villous amomum fruit, the virgate wormwood herb, the immature bitter orange, the officinal magnolia bark and the honey-fried licorice root into water 7 times of the total mass of the traditional Chinese medicines, soaking for 30min at 20 ℃, heating to 90 ℃, decocting for 35min, and filtering to obtain a leaching solution to obtain a traditional Chinese medicine extract.
The traditional Chinese medicine extract with the function of treating the Hp-related gastritis is prepared into traditional Chinese medicine oral liquid by adopting a conventional method.
Example 4
The traditional Chinese medicine extract is prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 12g of basil; 4g of fructus evodiae; 12g of zanthoxylum bungeanum maxim; 12g of black nightshade; 14g of Indian mockstrawberry herb; 14g of wrinkled gianthyssop herb; 14g of eupatorium fortunei; 14g of fructus amomi; 22g of oriental wormwood; 14g of immature bitter orange; 14g of magnolia officinalis and 8g of honey-fried licorice root.
The preparation method of the traditional Chinese medicine extract specifically comprises the following steps:
adding the basil, the evodia rutaecarpa, the pricklyash peel, the black nightshade, the Indian mockstrawberry herb, the wrinkled gianthyssop herb, the fortune eupatorium herb, the villous amomum fruit, the virgate wormwood herb, the immature bitter orange, the officinal magnolia bark and the honey-fried licorice root into water which is 6 times of the total mass of the traditional Chinese medicines, soaking the mixture for 40min at 20 ℃, heating the mixture to 80 ℃, decocting the mixture for 30min, and filtering the leaching solution to obtain the traditional Chinese medicine extract.
The traditional Chinese medicine extract with the function of treating the Hp-related gastritis is prepared into traditional Chinese medicine granules by adopting a conventional method.
Example 5
The traditional Chinese medicine extract is prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 9g of basil; 3g of fructus evodiae; 9g of zanthoxylum bungeanum maxim; 9g of black nightshade; 12g of Indian mockstrawberry herb; 12g of wrinkled gianthyssop herb; 12g of eupatorium fortunei; 12g of fructus amomi; 20g of oriental wormwood; 12g of immature bitter orange; 12g of magnolia officinalis and 6g of honey-fried licorice root.
The preparation method of the traditional Chinese medicine extract specifically comprises the following steps:
adding the basil, the evodia rutaecarpa, the pricklyash peel, the black nightshade, the Indian mockstrawberry herb, the wrinkled gianthyssop herb, the fortune eupatorium herb, the villous amomum fruit, the virgate wormwood herb, the immature bitter orange, the officinal magnolia bark and the honey-fried licorice root into water which is 6 times of the total mass of the traditional Chinese medicines, soaking for 40min at 25 ℃, heating to 90 ℃, decocting for 30min, and filtering to obtain leaching liquor so as to obtain the traditional Chinese medicine extract.
The traditional Chinese medicine extract with the function of treating the Hp-related gastritis is prepared into traditional Chinese medicine oral liquid by adopting a conventional method.
Comparative example 1
A traditional Chinese medicine extract with a function of treating Hp-related gastritis is prepared by decocting traditional Chinese medicine raw materials with water, wherein on the basis of example 1, zanthoxylum seeds are replaced by equal amount of tuckahoe, Indian mockstrawberry is replaced by equal amount of andrographis paniculata, other components are the same as example 1, and the traditional Chinese medicine raw materials comprise the following components in parts by mass: 5g of basil; 5g of fructus evodiae; 5g of poria cocos; 5g of black nightshade; 8g of common andrographis herb; 8g of wrinkled gianthyssop herb; 8g of eupatorium fortunei; 8g of fructus amomi; 25g of oriental wormwood; 16g of immature bitter orange; 16g of magnolia officinalis and 2g of honey-fried licorice root.
The preparation method of the traditional Chinese medicine extract specifically comprises the following steps:
adding the above herba Ocimi, fructus evodiae, Poria, herba Solani Nigri, herba Andrographitis, herba Agastaches, herba Eupatorii, fructus Amomi, herba Artemisiae Scopariae, fructus Aurantii Immaturus, cortex Magnolia officinalis and radix Glycyrrhizae Preparata into 6 times of water, soaking at 25 deg.C for 40min, heating to 100 deg.C, decocting for 30min, and filtering to obtain extractive solution.
The traditional Chinese medicine extract with the function of treating the Hp-related gastritis is prepared into traditional Chinese medicine oral liquid by adopting a conventional method.
In order to better illustrate the characteristics of the traditional Chinese medicine extract for treating Hp-related gastritis provided by the embodiment of the invention, the traditional Chinese medicine extracts prepared in example 1 and comparative example 1 are tested for prevention and treatment effects.
The present invention is described in further detail below in connection with clinical trials and typical cases.
First, clinical test
1. Clinical data:
1.1 general data
180 patients with outpatient and hospitalized Hp-related gastritis were selected and divided into 3 groups by the eRankine method, i.e., 60 patients in each of the example-treated group, the comparative example-treated group and the control group. Among these, 38 men and 22 women were treated. Mean (40.75 ± 11.71 years), 35 men and 25 women in the control treatment group. Mean (41.65. + -. 11.62 years), 36 men and 14 women in the control group. Mean (39.83 ± 11.55 years old). The general data comparison is not statistically significant (P >0.05), and the difference is comparable.
1.2 diagnostic criteria
The Western medicine diagnosis standard refers to the Chinese Chronic gastritis consensus opinion (2017, Shanghai), the Chinese and Western medicine combination diagnosis and treatment consensus opinion for chronic non-atrophic gastritis (2017), the Chinese and Western medicine combination diagnosis and treatment consensus opinion for chronic atrophic gastritis (2017), and the Chinese medicine diagnosis standard refers to the Chinese medicine new drug clinical guidance research principle.
The method specifically comprises the following steps: (1) clinical symptoms: fullness or pain in the stomach, nausea, vomiting, poor appetite, eructation, acid regurgitation, dry mouth, bitter taste; (2) and passed through laboratory 14CPositive in breath test; (3) gastroscope, pathological diagnosis are CAG (with intestinal or intraepithelial neoplasia) or CSG (with erosion or bile reflux).
1.3 inclusion criteria
The gastroscope diagnoses chronic gastritis and has clinical symptoms; ② 20-70 years old; ③ Hp positive patients; (iv) receiving the treatment for eradication of Hp for the first time; signing an informed consent.
1.4 exclusion criteria
Antibiotic, bismuth agent and PPI are used in the first two weeks of treatment; second, the patient has the operation history of the digestive tract; ③ pregnant and lactating women; fourthly, people with allergic constitution or people allergic to various medicines; fifthly, patients with serious primary diseases and mental diseases such as liver, kidney and hematopoietic system are combined.
2. The treatment method comprises the following steps:
examples the treatment group, the comparative treatment group and the control group were all given tetrad bactericidal drugs: the esomeprazole magnesium enteric-coated tablet (Aslicon pharmaceutical Co., Ltd., national drug standard number H20046379, specification: 20mg multiplied by 7 tablets) is 20mg each time, 2 times per day; ornidazole dispersible tablet (Hunan Jiuzhan pharmaceutical Co., Ltd., national Standard number H20040460, specification: 0.25g × 24 tablets) 0.5g each time, 2 times/day; amoxicillin dispersible tablets (Shanxi Tongda pharmaceutical industry Co., Ltd., national drug Standard number H20000492, specification: 500mg X24 tablets) 1.0g each time, 2 times per day; bismuth potassium citrate granules (Lizhu group Lizhu pharmaceutical factory, national standard number H10900086, specification: 1.0g × 56 bags) are treated for 2 weeks 1.0g each time and 2 times per day.
2.1 treatment group of examples: administering 300 ml/dose of the traditional Chinese medicine extract obtained in the embodiment 1 of the invention, 1 dose per day, warm taking twice, and oral taking for 4 weeks; comparative example treatment group: the extract of the Chinese traditional medicine obtained in comparative example 1 was administered at 300 ml/dose, 1 dose per day, twice with warm water, and orally for 4 weeks.
2.2 control group: the placebo (200 g of rice, parched to brown and 1/20 of the amount of the raw material medicament in example 1, the Chinese medicinal extract prepared by the method in example 1) of the Chinese medicament is administered at a dose of 300 ml/dose, 1 dose per day, and the oral administration is carried out for 4 weeks by warm taking twice.
3. Observation indexes are as follows: clinical symptoms, Hp, gastroscopy, pathology.
3.1 clinical symptoms: fullness or pain in the stomach, nausea, vomiting, poor appetite, belching, acid regurgitation, dry mouth and bitter taste. The accumulation of symptom scores is carried out according to the severity of clinical symptoms of patients, the score of heavy, medium, light and none is respectively 3, 2, 1 and 0, and the higher the score is, the more serious the symptoms are, and vice versa. The treatment period was recorded weekly.
3.2 Hp: the patient is on an empty stomach in the early morning, and the physician guides the patient to complete the operation, and the detection is carried out by adopting a HUBT-01 Hp detector of Shenzhen Zhonghehai De Wei Biotech Co. The rate of eradication of Hp is 100% per total number of negative cases.
3.3 gastroscope: the patient had an empty stomach in the morning and was examined by a specialist using a GIF-H260 gastroscope, manufactured by Olympus, Japan. According to the consensus of Chinese Chronic gastritis (2017, Shanghai), the gastric mucosa under gastroscope is divided into 0, 1, 2 and 3 points according to the condition of absence, lightness, middle and weight of the gastric mucosa, such as erythema, roughness or edema, hemorrhage or speckle, erosion, bile reflux, blood vessel appearance, and granule or nodular shape.
3.4 pathological conditions: during operation, biopsy is carried out by collecting lesion parts by biopsy forceps, fixing is carried out by adopting 10% formalin solution, dehydrated paraffin is embedded, and HE staining is adopted. The histopathological evaluation criteria, i.e., activity, chronic inflammation, atrophy and intestinal metaplasia, were made according to the consensus on chronic gastritis (2017, Shanghai) and were counted as 0, 1, 2 and 3 points for none, light, medium and heavy points, respectively.
4. The evaluation standard of curative effect is as follows:
referring to the clinical guidance and research principles of new traditional Chinese medicines, clinical cure is as follows: the symptom and the physical sign disappear or basically disappear, the symptom score is reduced by more than or equal to 95 percent, 14 percentCThe test turns negative, and the symptom integral and the histopathology integral of the mucosa under the gastroscope are reduced by more than or equal to 95 percent; the effect is shown: the symptoms and physical signs are obviously improved, the symptom score is reduced by more than or equal to 70 percent, 14 percentCThe test turns negative, and the symptom integral and the histopathology integral of the mucosa under the gastroscope are reduced by more than or equal to 70 percent; the method has the following advantages: the symptoms and physical signs are all improved, the symptom score is reduced by more than or equal to 30 percent, 14 percentCThe test is positive, the symptom integral and the histopathology integral of mucosa under the gastroscope are reduced by more than 50 percent; and (4) invalidation: clinical symptoms and physical signs are not relieved or aggravated, the symptom integral is reduced by less than 30 percent compared with the prior one, the symptom integral of mucosa under a gastroscope and the histopathology integral are reduced by less than 50 percent, and a nimodipine method is adopted as a calculation formula of the reduction percentage of the symptom integral.
5. Before and after treatment, the blood, urine and stool routine of the patient, electrocardiogram, liver and kidney functions, gastrointestinal adverse reactions and the like are detected.
6. The statistical method comprises the following steps:
data were statistically analyzed using SPSS25.0 software. The measured data conforms to the normal distribution with mean + -standard deviation
Represents; adopting pairing t test before and after treatment in the group, comparing between groups, if normal distribution is met, selecting two independent samples for t test, and if not, selecting rank sum test; and the grade curative effect evaluation data adopts rank sum test. The difference is statistically significant when P is less than 0.05.
7. The treatment results are as follows:
7.1 Total score of chief complaints after treatment of three groups of patients (as shown in Table 1): fullness or pain in the stomach, nausea, vomiting, poor appetite, belching, acid regurgitation, dry mouth and bitter taste.
TABLE 1 Total score of chief complaints after treatment
Note: the total score of the symptoms before the two groups of treatments was not statistically significant (P)>0.05), treatment group pre-treatment comparison P<0.05, post-treatment compared to control group△P<0.05。
As can be seen from the data in Table 1, the total score of the three pre-treatment groups was not statistically significant (P)>0.05), the total integral of symptoms was significantly reduced and the difference P was significant before and after treatment in the treatment groups of examples<0.05, the total integral of symptoms of the treatment groups of the examples is obviously reduced and the difference is obvious compared with that of the control group after treatment△P<0.05, and the effect of the treatment group of the embodiment is better than that of the treatment group of the comparative example.
7.2 comparison of the clinical effects of the three groups
As shown in table 2, the treatment groups of the examples clinically cured 31 cases, the significant effect of 21 cases, the effective cases of 7 cases, and the ineffective cases of 1 case, the rate of eradication of Hp was 86.67%, and the total effective rate was 98.33%, the treatment groups of the comparative examples clinically cured 27 cases, the significant effect of 19 cases, the effective cases of 11 cases, and the ineffective cases of 3 cases, the rate of eradication of Hp was 86.67%, and the total effective rate was 98.33%, the clinical cure of the control groups was 23 cases, the significant effect of 17 cases, the effective cases of 14 cases, the ineffective cases of 6 cases, the rate of eradication of Hp was 68.33%, and the total effective rate was 90%, and the two groups had significant differences (P < 0.05).
TABLE 2
7.3 integration of the endoscopic mucosal signs before and after treatment in three groups of patients
As shown in Table 3, the score of gastric mucosa signs before three groups of treatments is not statistically significant (P >0.05), the score of gastric mucosa signs of patients in the treatment groups of the examples after the treatment is reduced compared with that before the treatment and is superior to that of the control group, the difference is statistically significant (P <0.05), and meanwhile, the effect of the treatment groups of the examples is superior to that of the treatment groups of the comparative examples.
TABLE 3
7.4 integration of histopathological changes before and after treatment in three groups of patients
As shown in Table 4, the number of people in each period before the three groups had no statistical significance (P)>0.05), the histopathological change score is obviously reduced and the difference is obvious P compared with the treatment group of the example before and after treatment<0.05, the histopathology change score of the example treated group is obviously reduced and the difference is obvious compared with that of the control group after treatment△ P<0.05, the effect of the treatment group of the example was superior to that of the treatment group of the comparative example.
TABLE 4
7.5 adverse reaction results for three groups of patients are shown in Table 5.
TABLE 5
Note: p of the treatment group is less than 0.05 compared with the control group
According to the data, the traditional Chinese medicine extract with the function of treating the Hp-related gastritis provided by the embodiment of the invention is prepared by supplementing 12 medicines, monarch, minister, assistant and guide, has the effects of warming yang, resolving turbidity and detoxifying, is safe and reliable, has no toxic or side effect, can effectively improve the eradication rate of helicobacter pylori, can reduce the side effect of a bactericidal medicine, promotes the repair of gastric mucosa, and has an obvious effect.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents or improvements made within the spirit and principle of the present invention should be included in the scope of the present invention.
Claims (10)
1. The traditional Chinese medicine extract for treating helicobacter pylori-associated gastritis is characterized by being prepared by decocting traditional Chinese medicine raw materials with water, wherein the traditional Chinese medicine raw materials comprise the following components in parts by mass: 5-14 parts of basil; 2-5 parts of fructus evodiae; 5-14 parts of zanthoxylum seeds; 5-14 parts of black nightshade; 8-16 parts of mock strawberry; 8-16 parts of agastache rugosus; 8-16 parts of eupatorium; 8-16 parts of fructus amomi; 15-25 parts of oriental wormwood; 8-16 parts of immature bitter orange; 8-16 parts of mangnolia officinalis and 2-12 parts of honey-fried licorice root.
2. The traditional Chinese medicine extract with the function of treating helicobacter pylori-associated gastritis as claimed in claim 1, wherein the traditional Chinese medicine raw materials consist of the following components in parts by mass: 7-12 parts of basil; 2-4 parts of fructus evodiae; 7-12 parts of zanthoxylum seeds; 7-12 parts of black nightshade; 10-14 parts of mock strawberry; 10-14 parts of agastache rugosus; 10-14 parts of eupatorium; 10-14 parts of fructus amomi; 18-22 parts of oriental wormwood; 10-14 parts of immature bitter orange; 10-14 parts of mangnolia officinalis and 4-8 parts of honey-fried licorice root.
3. The traditional Chinese medicine extract with the function of treating helicobacter pylori-associated gastritis as claimed in claim 1, wherein the traditional Chinese medicine raw materials consist of the following components in parts by mass: 9 parts of basil; 3 parts of fructus evodiae; 9 parts of zanthoxylum seeds; 9 parts of black nightshade; 12 parts of Indian mockstrawberry herb; 12 parts of wrinkled gianthyssop herb; 12 parts of eupatorium; 12 parts of fructus amomi; 20 parts of oriental wormwood; 12 parts of immature bitter orange; 12 parts of magnolia officinalis and 6 parts of honey-fried licorice root.
4. The method for preparing the Chinese herbal extract for treating helicobacter pylori-associated gastritis according to any one of claims 1 to 3, comprising the steps of:
soaking herba Ocimi, fructus evodiae, semen Zanthoxyli, herba Solani Nigri, herba Duchesneae Indicae, herba Agastaches, herba Eupatorii, fructus Amomi, herba Artemisiae Scopariae, fructus Aurantii Immaturus, cortex Magnolia officinalis and radix Glycyrrhizae Preparata in water, heating, decocting, and filtering to obtain extractive solution.
5. The method for preparing the Chinese herbal extract for treating helicobacter pylori-associated gastritis according to claim 4, wherein the preparation method comprises the following steps: the soaking temperature is 15-25 ℃, and the soaking time is 30-60 min.
6. The method for preparing the Chinese herbal extract for treating helicobacter pylori-associated gastritis according to claim 4, wherein the preparation method comprises the following steps: the decoction temperature is 80-100 ℃, and the time is 30-40 min.
7. The method for preparing the Chinese herbal extract for treating helicobacter pylori-associated gastritis according to claim 4, wherein the preparation method comprises the following steps: the water dosage is 6-8 times of the total mass of the traditional Chinese medicine.
8. A Chinese medicinal preparation for treating helicobacter pylori-associated gastritis, which is prepared from the Chinese medicinal extract for treating helicobacter pylori-associated gastritis according to any one of claims 1 to 3.
9. The traditional Chinese medicine preparation with the function of treating helicobacter pylori-associated gastritis according to claim 8, wherein the dosage form of the traditional Chinese medicine preparation is oral liquid, capsules, tablets, granules or pills.
10. Use of the extract of a traditional Chinese medicine having a function of treating helicobacter pylori-associated gastritis as defined in any one of claims 1 to 3 in the preparation of a medicament having a function of treating helicobacter pylori-associated gastritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011040023.7A CN111991535B (en) | 2020-09-28 | 2020-09-28 | Traditional Chinese medicine extract with function of treating helicobacter pylori-associated gastritis and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011040023.7A CN111991535B (en) | 2020-09-28 | 2020-09-28 | Traditional Chinese medicine extract with function of treating helicobacter pylori-associated gastritis and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111991535A CN111991535A (en) | 2020-11-27 |
| CN111991535B true CN111991535B (en) | 2021-10-26 |
Family
ID=73475418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011040023.7A Active CN111991535B (en) | 2020-09-28 | 2020-09-28 | Traditional Chinese medicine extract with function of treating helicobacter pylori-associated gastritis and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111991535B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102491196B1 (en) * | 2021-03-11 | 2023-01-20 | 전남대학교 산학협력단 | Composition for Improving, Preventing or Treating Helicobacter pylori Infection |
| CN115554374B (en) * | 2022-10-13 | 2023-07-07 | 河北中医学院 | Traditional Chinese medicine composition for treating helicobacter pylori gastritis as well as preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385837A (en) * | 2008-10-16 | 2009-03-18 | 杨启泽 | Chinese prepared medicine for treating gastrosis |
| CN104645202A (en) * | 2015-01-30 | 2015-05-27 | 河北省中医院 | Traditional Chinese medicine preparation for treating chronic gastritis |
| CN108114227A (en) * | 2017-10-25 | 2018-06-05 | 马雪英 | A kind of drug for treating stomachache and preparation method thereof |
| CN109289033A (en) * | 2018-12-19 | 2019-02-01 | 吴其东 | A kind of Chinese medicine composition that treating cold-dampness stomach trouble and preparation method |
-
2020
- 2020-09-28 CN CN202011040023.7A patent/CN111991535B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101385837A (en) * | 2008-10-16 | 2009-03-18 | 杨启泽 | Chinese prepared medicine for treating gastrosis |
| CN104645202A (en) * | 2015-01-30 | 2015-05-27 | 河北省中医院 | Traditional Chinese medicine preparation for treating chronic gastritis |
| CN108114227A (en) * | 2017-10-25 | 2018-06-05 | 马雪英 | A kind of drug for treating stomachache and preparation method thereof |
| CN109289033A (en) * | 2018-12-19 | 2019-02-01 | 吴其东 | A kind of Chinese medicine composition that treating cold-dampness stomach trouble and preparation method |
Non-Patent Citations (4)
| Title |
|---|
| 半夏泻心汤加减治疗慢性浅表性胃炎53例;易敏文等;《湖北中医杂志》;19900430(第02期);全文 * |
| 半夏泻心汤加味治疗慢性胃炎40例;让建忠;《中国民间疗法》;20100331(第03期);全文 * |
| 慢性胃炎用药浅析;王体福;《泸州医学院学报》;19970831(第04期);全文 * |
| 辨证分型治疗慢性萎缩性胃炎34例疗效观察;李翠竹;《中国社区医师》;20080131(第02期);全文 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111991535A (en) | 2020-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111671880B (en) | Traditional Chinese medicine preparation for treating fever caused by coronavirus pneumonia | |
| CN111991535B (en) | Traditional Chinese medicine extract with function of treating helicobacter pylori-associated gastritis and preparation method and application thereof | |
| CN103751739A (en) | Traditional Chinese medicine composition for treating chronic gastritis, application of composition in preparation of medicine for treating chronic gastritis, and preparation method of composition | |
| CN113713057B (en) | Traditional Chinese medicine composition and application thereof | |
| CN113209238A (en) | Lotion for treating hand-foot syndrome caused by targeted medicament and preparation method thereof | |
| CN104083747B (en) | A kind of pharmaceutical composition for treating chronic gastritis and preparation method and purposes | |
| CN113768978B (en) | Yi medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN101693084B (en) | Medical composition for treating epigastric pain yin deficiency syndrome and preparation method thereof | |
| CN110856741A (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating diarrhea | |
| CN105833115B (en) | Traditional Chinese medicine for treating gastric precancerous lesion | |
| CN104225016B (en) | A kind of pharmaceutical composition treating due to weakness of spleen and stomach chronic atrophic gastritis | |
| CN111228367B (en) | Traditional Chinese medicine external lotion for treating infantile anaphylactoid purpura and preparation method thereof | |
| CN105395975A (en) | Enema traditional Chinese medicine composition treating ulcerative colitis and preparation method thereof | |
| CN1903347A (en) | Medicine composition for treating alimentary canal diseases, prepn. method and application thereof | |
| CN105412822A (en) | Spleen-strengthening blood stasis-removing Chinese herbal compound composition and application thereof | |
| CN111494583A (en) | A pharmaceutical composition for treating chronic atrophic gastritis and preparation method thereof | |
| CN115554374B (en) | Traditional Chinese medicine composition for treating helicobacter pylori gastritis as well as preparation method and application thereof | |
| CN113633748B (en) | Medicine for treating spontaneous bacterial peritonitis damp-heat stasis syndrome of liver cirrhosis and preparation method thereof | |
| CN116159110B (en) | New use of compound traditional Chinese medicine for resolving dampness and clearing spots in treating Behcet disease | |
| CN104208474B (en) | Traditional Chinese medicine composition for treating acute urinary tract infection and application thereof | |
| CN113769002B (en) | Traditional Chinese medicine decoction for treating gastritis verrucosa | |
| CN116920057B (en) | Traditional Chinese medicine composition for treating acute and chronic gastritis and application thereof | |
| CN102697990A (en) | Traditional Chinese medicine composition used for treating perianorecrtal abscess | |
| CN102688306B (en) | Ointment for treating acute pancreatitis | |
| CN112451605B (en) | Enema formula for treating spleen deficiency and damp-heat syndrome in active stage of chronic ulcerative colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |